Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05356234 · ClinicalTrials.gov registry record · NA
Ignite Study of the Jewish Family and Children's Service of the Suncoast, Inc.
A NA study of Intervention and Wait-List Control, sponsored by Jewish Family & Children's Service of the Suncoast.
- Recruiting
- Registry status
- NA
- Development phase
- 675
- Enrollment target
- 1
- Study location
NCT05356234: Recruiting NA study of Intervention and Wait-List Control, sponsored by Jewish Family & Children's Service of the Suncoast.
NCT05356234 is a NA study of Intervention and Wait-List Control that is actively recruiting participants, run by Jewish Family & Children's Service of the Suncoast. The registered enrollment target is 675 participants, above the 190-participant average among 6 other Intervention trials with a reported enrollment target (255% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05356234, a NA study of Intervention and Wait-List Control, is actively recruiting participants, sponsored by Jewish Family & Children's Service of the Suncoast.
- RECRUITING
- Registry status
- NA
- Development phase
- 675 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of the program are to help struggling fathers and father figures improve the parent-child relationship, sustain healthy marriages and relationships (and help those who are single identify ways to enter into safe and supportive relationships that may ultimately lead to marriage), and identify and support fathers in their economic stability and employment objectives. These outcomes will be achieved through a series of workshops addressing responsible parenting and marriage and relationships as well as a complement of employment services and comprehensive case management. Additional services needed by participants will be identified and provided either through wraparound programming provided by JFCS or through collaborative agreements with local partner agencies. Additionally, Ignite will incorporate a comprehensive employment program combining both job and career advancement.
Primary Outcome
The FES was developed to measure social and environmental characteristics of families. Face and content validity are supported by clear statements about family situations that relate to subscale domains, and the measure can differentiate between distressed and normal family samples.
Conditions Studied
Interventions
- BEHAVIORAL Treatment Intervention: Responsible Parenting, Relationships, and Employment Services
Study Locations (1)
Florida
- Jewish Family and Children Service of the Suncoast, Inc. - Sarasota
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 675 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2025-06-01 |
| Phase | NA |
What NCT05356234 shows while recruiting
NCT05356234 is an interventional study that assigns participants to a tested intervention. The registered 675 participants enrollment target is mid-sized for trials with a published cap, above the 190-participant average among 6 other Intervention trials with a reported enrollment target (255% higher).
The record links to 2 conditions, with Intervention appearing as the primary indexed condition, and to 1 intervention - of which Treatment Intervention: Responsible Parenting, Relationships, and Employment Services is the first listed.
NCT05356234 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05356234 about?
NCT05356234 is a clinical study titled "Ignite Study of the Jewish Family and Children's Service of the Suncoast, Inc.". The goals of the program are to help struggling fathers and father figures improve the parent-child relationship, sustain healthy marriages and relationships (and help those who are single identify ways to enter into safe and supportive relationships that may ultimately lead to marriage), and identi...
What is the current status of trial NCT05356234?
This trial is currently recruiting. It is a NA study. The enrollment target is 675 participants. The study started on 2022-04-01. Estimated completion is 2025-06-01.
What conditions does trial NCT05356234 study?
This clinical trial studies the following conditions: Intervention, Wait-List Control.
What interventions are being tested in trial NCT05356234?
The interventions under investigation include: Treatment Intervention: Responsible Parenting, Relationships, and Employment Services (BEHAVIORAL).
Who is sponsoring clinical trial NCT05356234?
This trial is sponsored by Jewish Family & Children's Service of the Suncoast, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05356234 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intervention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Restoring Empowerment and Choosing Hope (REACH)
RECRUITING · NA
-
Comparing Telehealth to In-person a Combined Metacognitive Training in Veterans With mTBI/PTSD
RECRUITING · NA
-
Coaching Teachers in Bullying Detection and Intervention
RECRUITING · NA
-
Family Navigator Plus for Foster Parents
RECRUITING · NA
-
Improving Health Outcomes With Resource Facilitation
COMPLETED · NA
-
Learning Skills Together Pilot Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04788277 · 675 participants
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
- NCT06070870 · 675 participants · NA
Health Education Approach to Lung Screening
- NCT06357533 · 675 participants · Phase 3
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
- NCT06461897 · 675 participants · Phase 3
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI